Product
Help
Pricing
About
Jobs
Log in
Get started
Institution
Add to collection
Ocugen, Inc. (United States)
Homepage:
ocugen.com
Alternate names:
Ocugen,
Ocugen, Inc.
ROR:
0194jyj31
OpenAlex ID:
I4405267114
Gene Therapy for Retinal Degenerative Diseases: Progress, Challenges, and Future Directions
2023
·
Selina Drag
, Farokh Dotiwala
, et al.
·
Investigative Ophthalmology & Visual Science
·
150
Nr2e3 is a genetic modifier that rescues retinal degeneration and promotes homeostasis in multiple models of retinitis pigmentosa
2020
·
Sujun Li
, Shyamtanu Datta
, et al.
·
Gene Therapy
·
74
PDF
Next Generation Mucosal Vaccine Strategy for Respiratory Pathogens
2023
·
Farokh Dotiwala
, Arun K. Upadhyay
·
Vaccines
·
71
PDF
Sensory Neuron-Specific Deletion of Tropomyosin Receptor Kinase A (TrkA) in Mice Abolishes Osteoarthritis (OA) Pain via NGF/TrkA Intervention of Peripheral Sensitization
2022
·
InSug O-Sullivan
, Ranjan Kc
, et al.
·
International Journal of Molecular Sciences
·
32
PDF
Geographic atrophy: pathophysiology and current therapeutic strategies
2023
·
Kalpana Rajanala
, Farokh Dotiwala
, et al.
·
Frontiers in Ophthalmology
·
23
PDF
Advancing AAV vector manufacturing: challenges, innovations, and future directions for gene therapy
2025
·
N. Charan S. S. Kowshik
, Pushpendra Singh
·
Frontiers in Molecular Medicine
·
22
PDF
Retinoic acid related orphan receptor α is a genetic modifier that rescues retinal degeneration in a mouse model of Stargardt disease and Dry AMD
2024
·
M. Akula
, S. M. McNamee
, et al.
·
Gene Therapy
·
22
Harmonization of Vaccine Ligand Binding Assays Validation
2024
·
Francis Dessy
, Ivo Sonderegger
, et al.
·
Bioanalysis
·
17
PDF
Stargardt’s Disease: Molecular Pathogenesis and Current Therapeutic Landscape
2025
·
Kunal Dayma
, Kalpana Rajanala
, et al.
·
International Journal of Molecular Sciences
·
15
PDF
Vaccines for Respiratory Viruses—COVID and Beyond
2024
·
Kalpana Rajanala
, Arun Kumar Upadhyay
·
Vaccines
·
13
PDF
A comprehensive review of BBV152 vaccine development, effectiveness, safety, challenges, and prospects
2022
·
Farokh Dotiwala
, Arun K. Upadhyay
·
Frontiers in Immunology
·
11
PDF
Epigenetic Switches in Retinal Homeostasis and Target for Drug Development
2024
·
Kalpana Rajanala
, Arun Upadhyay
·
International Journal of Molecular Sciences
·
10
PDF
Preclinical dose response study shows NR2E3 can attenuate retinal degeneration in the retinitis pigmentosa mouse model RhoP23H+/−
2024
·
Shannon M. McNamee
, Natalie P. Chan
, et al.
·
Gene Therapy
·
10
PDF
Safety and Efficacy Results From a Phase 1/2 Clinical Trial of Ocu400 Modifier Gene Therapy for Treatment of Retinitis Pigmentosa
2024
·
A.K. Upadhyay
, H. Qamar
, et al.
·
Cytotherapy
·
6
Evaluating therapeutic potential of NR2E3 doses in the rd7 mouse model of retinal degeneration
2024
·
Shannon M. McNamee
, Monica Akula
, et al.
·
Scientific Reports
·
4
PDF
A novel modifier gene therapy to treat Stargardt disease: Phase 1 GARDian1 Trial Insights
2026
·
Arshad M. Khanani
, Lejla Vajzovic
, et al.
·
Eye
·
3
PDF
Loss of PKCδ/Prkcd prevents cartilage degeneration in joints but exacerbates hyperalgesia in an experimental osteoarthritis mouse model
2023
·
Gurjit Singh
, InSug O-Sullivan
, et al.
·
Gene
·
3
Choosing Outcome Measures and Assessing Efficacy of Therapeutic Interventions in Inherited Retinal Diseases: The Importance of Natural History Studies
2021
·
Alessandro Iannaccone
, Oleg Alekseev
·
International Ophthalmology Clinics
·
3
Correction: Nr2e3 is a genetic modifier that rescues retinal degeneration and promotes homeostasis in multiple models of retinitis pigmentosa
2024
·
Sujun Li
, Shyamtanu Datta
, et al.
·
Gene Therapy
·
2
PDF
Gene delivery for cerebral neurodegenerative disorders: Current advancements and limitations
2026
·
Kunal Dayma
, Arun Upadhyay
·
Molecular Therapy
·
1
Vaccine Ligand Binding Assay Life Cycle Management, Assay Maintenance, Monitoring and Transfer
2026
·
Jeroen Stoop
, James Huleatt
, et al.
·
Bioanalysis
·
1
PDF
Preclinical biodistribution and toxicology assessment of an AAV5-based subretinal modifier gene therapy for retinitis pigmentosa
2025
·
Arun Upadhyay
, Selina Drag
, et al.
·
Frontiers in Medicine
·
1
PDF
OCU200 (transferrin-tumstatin fusion protein): A potential therapeutic for DME, DR, and wet-AMD
2021
·
Arun K. Upadhyay
, Rasappa Arumugham
, et al.
·
Investigative Ophthalmology & Visual Science
·
1
Preclinical efficacy of AAV5-Nr2e3 in the mouse model of Nr2e3 mutation associated inherited retinal degeneration
2020
·
Arun K. Upadhyay
, Shyamtanu Datta
, et al.
·
Investigative Ophthalmology & Visual Science
·
1
Retinoic acid-related orphan receptor alpha (RORα) as a candidate multi-pathway target in Alzheimer’s disease: mechanisms and therapeutic prospects
2026
·
Shivakanth Chintalapally
, Kalpana Rajanala
, et al.
·
Frontiers in Neuroscience
Show more works
View as search
Works count:
28
Citation count:
1,182
Year
Topic
Type
